I can't believe we'll have to wait that long for results. That doesn't make sense; I mean, we already at least have some indication of the IMMUNOGENICITY of the Moderna and Pfizer vaccines (well, at least after dose 1, but that's something). Surely it doesn't take 3 years to mount an antibody response. I can maybe understand them waiting so long to see for how long protection might last, but 3 years? Did no one think to research this earlier because I know I got my Shingrix shots before Emory's study began.
Quote from: MooseMom on March 16, 2021, 04:43:54 PMI can't believe we'll have to wait that long for results. That doesn't make sense; I mean, we already at least have some indication of the IMMUNOGENICITY of the Moderna and Pfizer vaccines (well, at least after dose 1, but that's something). Surely it doesn't take 3 years to mount an antibody response. I can maybe understand them waiting so long to see for how long protection might last, but 3 years? Did no one think to research this earlier because I know I got my Shingrix shots before Emory's study began.When I had my first meeting with my second ID doctor (now onto my third! everyone keeps moving for better jobs ) they ran blood work to get a benchmark and see what was up. It was then I learned I had to redo my Hep B vaccines (it happens in renal patients) so I wonder why they haven't looked for immunogenicity with Shringrix.
Many thanks for answering my questions, that was really kind of you and I am wondering about your Hep B vaccines (for renal patients?) and "Shingrix" ?I was not offered any of these vaccinations and wonder whether I should ask the medics about it?
Hi. Just curious- u were able to get Hep B vaccine w a transplant? I know as a teenager my work wanted me to get Hep B vax bc I was a lifeguard, but my neph said i couldn’t get it bc it was a live vaccine. (I also couldn’t get the yellow fever vax before my Africa trip bc it is a live vaccine, tho I did Iget typhus and Hep A then).
To make it more complex he was not willing to write an order for it, he wants it done at his site so it needs to be preordered before my visit, he has explained that the risks are too high for me to risk a pharmacy giving me the wrong live shot.
I didn't sleep either. Must be a part of KDK initiation. ETA: I just heard from a European contact that has been fully vaccinated (2 shots) with Pfizer. Had antibodies checked. Looks like after the second dose that there wasn't an antibody spike (at least in his case). Now that might be just him, but ugh. Need to think positive for the next installment of the study....
... And many thanks to UT for including your EU-contact's experiences after their second Pfizer-Vaccine! That's the news I was hoping for to "get" some encouragement etc.!!! I have already heard from a few people here who already had their second "Pfizer-shot" and they do very well, apart from feeling a little bit tired and exhausted. But since spring-time is approaching, their symptoms could also be a combination of "Pfizer-second-shot-tiredness" plus a little bit of early spring-tiredness?Many thanks again for your kind information and best wishes from Kristina.
This older story implies that the lack of antibodies might not mean lack of protection - I'm not saying its true, but I would like to know more about that in light of our bad news.https://www.washingtonpost.com/lifestyle/2021/02/12/covid-vaccine-antibody-test/How about an antibody test to determine if the vaccine was effective?The CDC discourages antibody testing for assessing immunity after getting the vaccine. In clinical trials, the Pfizer-BioNTech and Moderna vaccines were shown to protect people against the virus 95 percent of the time and 94 percent of the time, respectively. But that does not mean everyone who gets the vaccine would test positive for antibodies, Murphy said.Commercial antibody tests may not be searching for the same antibodies that the vaccine triggers. Someone who has had the vaccine and is immune to the virus may still test negative for certain antibodies, Murphy explained.Mutated virus may reinfect people already stricken once with covid-19, sparking debate and concernsIn any case, Murphy added, antibodies are only part of a person’s immune system response. Some studies have shown that protective T cells, a white blood cell that helps protect against disease, have been elevated in some patients with covid, even though the patients had no detectable antibodies.“After the vaccines, a lot people are going to get antibody testing — ‘Oh, I want to see if it’s working.’ It actually has very little correlation,” he said. “Many people will test negative on the antibody test, and that does not mean the vaccine didn’t work.”Also this makes it look less grim if its true:https://news.yahoo.com/vaccine-response-may-weaker-elderly-201942978.htmlThe COVID-19 vaccine from Pfizer Inc and German partner BioNTech SE induces weaker immune responses in elderly people compared to younger and middle-aged adults, new data suggest. Researchers studied 91 vaccine recipients under the age of 60 and 85 recipients over age 80. Seventeen days after the second of two doses, nearly one-third (31%) of the elderly recipients did not have any antibodies capable of neutralizing the virus. This was true for only 2% of the younger group, the researchers reported on Friday on medRxiv ahead of peer review. Even among those under age 60, only 16% had neutralizing antibodies after the first dose, the researchers found. "But that doesn't mean that the elderly should expect severe complications if they get infected," said coauthor Ortwin Adams of University Hospital Dusseldorf in Germany. "Recent reports from Israel, England and Scotland show that rates of hospitalization and severe disease progression are significantly lower than in the unvaccinated, even in people over 80 and even after the first COVID-19 vaccination," Adams said. "However, it could mean that the elderly need to be revaccinated sooner than young people to generate long-lasting protection. The results also suggest that transmissions may still be possible in some of the elderly after vaccination," he said, adding that "measures to effectively prevent transmissions should be continued."